• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Regulatory press release

Correction: 1Q26 Interim Report

Modulight

Modulight Corporation | Company Release | June 05, 2026 at 11:42:00 EEST

Modulight has identified an error in the presentation of certain balance sheet items in the financial statements released on 24-Apr-2026.

The error relates to the presentation of current liabilities. The amounts reported under accrued expenses and total current liabilities were incorrect.

The correct figures are as follows (EUR thousand):

Balance sheet itemPublished figureCorrect figure
Liabilities  
  Non-current liabilities  
      Loans from financial institutions988988
  Total non-current liabilities988988
  Current liabilities  
      Loans from financial institutions1,5021,502
      Advances received5353
      Accounts payable285285
     Other liabilities164164
     Accrued expenses1,0851,447
   Total current liabilities1,9493,451
Total liabilities4,4394,439

 
The correction does not affect the Company's total liabilities, total assets, shareholders' equity, cash flow, operating result, profit for the financial year, or any previously reported key performance indicators. The correction concerns only the presentation of balance sheet items.

The corrected figures have been updated in the financial statements available on the Company's website.
The Company regrets the error.

For further information, please contact:


CEO Seppo Orsila, m. +358 40 830 4671

IR Ulla Haapanen, m. +358 40 830 4676
Email: ir@modulight.com

Certified adviser: Sisu Partners Oy, m. +358 40 555 4727
 
modulight.com
@modulight

Modulight in brief


Modulight Corporation is a life science company that designs and manufactures laser devices for the treatment of cancer and eye diseases. The company also manufactures products for other high value-add applications including flow cytometry, microscopy, semiconductor, quantum, and defense. The company’s products include medical devices, subsystems, software, cloud services, and specialized semiconductors. Modulight’s products are used worldwide by many Fortune 500 companies, pharmaceutical companies, and well-known cancer centers and universities. Modulight was founded in 2000 and is headquartered in Tampere, Finland.

Follow Modulight: modulight.com | X | LinkedIn | Facebook | YouTube | Instagram | #KillCancer